Furthermore, a recent study reported that not only LMNA gene mutations, but also DSP, PKP2, and FLNC gene mutations in DCM cases are likely to cause sudden death and ventricular arrhythmia (19), supporting the usefulness of genetic testing in the clinical testing. This evidence concerns the gene DSP and familial dilated cardiomyopathy.